Insider · CIK 0001247340
HARRISON THOMAS L
Reports to the SEC for 10 companies · LEXINGTON, MA
Transactions
50
Companies
10
Filings
19
CIK
0001247340
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-10-01 | AGENAGENUS INCA Award | +$30.6K |
| 2026-08-05 | AGENAGENUS INC · Stock OptionA Award | — |
| 2026-07-01 | AGENAGENUS INCA Award | +$30.6K |
| 2026-04-24 | AGENAGENUS INC · Stock OptionA Award | — |
| 2026-04-20 | ACXPAcurx Pharmaceuticals, Inc. · Stock OptionA Award | — |
| 2026-04-01 | AGENAGENUS INCA Award | +$30.6K |
| 2026-01-02 | AGENAGENUS INCA Award | +$30.6K |
| 2025-11-20 | AFCGAdvanced Flower Capital Inc.A Award | +$15K |
| 2025-10-01 | AGENAGENUS INCA Award | +$29K |
| 2025-07-01 | AGENAGENUS INCA Award | +$25.6K |
| 2025-06-17 | AGENAGENUS INC · Stock OptionA Award | — |
| 2025-04-01 | AGENAGENUS INCA Award | +$25.6K |
| 2025-02-25 | AFCGAdvanced Flower Capital Inc.A Award | +$15K |
| 2024-08-07 | AGENAGENUS INC · Stock OptionA Award | — |
| 2024-06-17 | ACXPAcurx Pharmaceuticals, Inc. · Stock OptionA Award | — |
| 2024-01-24 | AFCGAdvanced Flower Capital Inc.A Award | +$15K |
| 2023-06-15 | ACXPAcurx Pharmaceuticals, Inc. · Stock OptionA Award | — |
| 2023-01-03 | AFCGAdvanced Flower Capital Inc.A Award | +$15K |
| 2022-01-11 | AFCGAdvanced Flower Capital Inc. · Stock Option (right to buy)A Award | — |
| 2021-07-01 | ACXPAcurx Pharmaceuticals, Inc. · Stock OptionA Award | — |
| 2021-03-23 | AFCGAdvanced Flower Capital Inc.P Purchase | +$95K |
| 2021-03-23 | AFCGAdvanced Flower Capital Inc. · Stock Option (right to buy)A Award | — |
| 2018-06-06 | Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2017-12-08 | Fifth Street Asset Management Inc.S Sale | −$24.3K |
| 2017-11-30 | Fifth Street Asset Management Inc.Option (right to buy)M Exercise/Conversion | — |
| 2017-11-30 | Fifth Street Asset Management Inc.S Sale | −$81.4K |
| 2017-11-30 | Fifth Street Asset Management Inc.M Exercise/Conversion | +$65.6K |
| 2017-11-30 | Fifth Street Asset Management Inc.Option (right to buy)M Exercise/Conversion | — |
| 2017-11-30 | Fifth Street Asset Management Inc.S Sale | −$81.4K |
| 2017-11-30 | Fifth Street Asset Management Inc.M Exercise/Conversion | +$65.6K |
| 2017-10-02 | Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award | +$11.3K |
| 2017-07-03 | Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award | +$11.2K |
| 2017-06-07 | Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2017-05-04 | Fifth Street Asset Management Inc.Option (right to buy)A Award | — |
| 2017-04-03 | Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award | +$11.2K |
| 2017-01-17 | PLx Pharma Winddown Corp.OptionsA Award | — |
| 2016-06-16 | Fifth Street Asset Management Inc.Option (right to buy)A Award | — |
| 2016-05-25 | Zynerba Pharmaceuticals, Inc.Stock Option (right to buy)A Award | — |
| 2016-03-14 | Fifth Street Asset Management Inc.Option (right to buy)A Award | — |
| 2016-01-19 | PLx Pharma Winddown Corp.OptionsA Award | +$183K |
| 2015-08-10 | Zynerba Pharmaceuticals, Inc.P Purchase | +$175K |
| 2015-08-04 | Zynerba Pharmaceuticals, Inc.Stock OptionA Award | — |
| 2015-06-04 | Fifth Street Asset Management Inc.Option (right to buy)A Award | — |
| 2015-01-05 | PLx Pharma Winddown Corp.OptionsA Award | +$170K |
| 2014-11-04 | Fifth Street Asset Management Inc.P Purchase | +$102K |
| 2014-10-29 | Fifth Street Asset Management Inc.Option (right to buy)A Award | — |
| 2014-03-18 | PLx Pharma Winddown Corp.P Purchase | +$24K |
| 2013-12-03 | RVUE HOLDINGS, INC.A Award | — |
| 2013-12-03 | RVUE HOLDINGS, INC.P Purchase | +$70K |
| 2013-03-12 | EPOCRATES INCNon-Qualified Stock Option (right to buy)D Disposition to Issuer | — |
Recent filings
- 4HARRISON THOMAS L0001193125-26-412039SEC(opens sec.gov)
- 4HARRISON THOMAS L0001193125-26-344617SEC(opens sec.gov)
- 4HARRISON THOMAS L0001193125-26-297094SEC(opens sec.gov)
- 4HARRISON THOMAS L0001193125-26-187082SEC(opens sec.gov)
- 4HARRISON THOMAS L0001104659-26-046840SEC(opens sec.gov)
- 4HARRISON THOMAS L0001193125-26-152886SEC(opens sec.gov)
- 4HARRISON THOMAS L0001193125-26-002395SEC(opens sec.gov)
- 4HARRISON THOMAS L0001247340-25-000006SEC(opens sec.gov)
- 4HARRISON THOMAS L0001193125-25-230100SEC(opens sec.gov)
- 4HARRISON THOMAS L0000950170-25-095865SEC(opens sec.gov)
- 4HARRISON THOMAS L0000950170-25-050373SEC(opens sec.gov)
- 4HARRISON THOMAS L0001247340-25-000002SEC(opens sec.gov)
- 4HARRISON THOMAS L0000950170-24-094126SEC(opens sec.gov)
- 4HARRISON THOMAS L0001104659-24-072810SEC(opens sec.gov)
- 4HARRISON THOMAS L0001822523-24-000004SEC(opens sec.gov)
- 4HARRISON THOMAS L0001104659-23-072371SEC(opens sec.gov)
- 4HARRISON THOMAS L0001209191-23-002038SEC(opens sec.gov)
- 4HARRISON THOMAS L0001140361-22-001641SEC(opens sec.gov)
- 4HARRISON THOMAS L0001104659-21-089410SEC(opens sec.gov)
Companies
- Acurx Pharmaceuticals, Inc.DirectorACXP
- Advanced Flower Capital Inc.DirectorAFCG
- AGENUS INCDirectorAGEN
- EPOCRATES INCDirector
- Fifth Street Asset Management Inc.Director
- Morgans Hotel Group Co.Director
- OMNICOM GROUP INC.Chrmn/CEO Divers. Agency Serv.OMC
- PLx Pharma Winddown Corp.Director
- RVUE HOLDINGS, INC.Director
- Zynerba Pharmaceuticals, Inc.Director
Address
C/O AGENUS INC. 3 FORBES ROAD
LEXINGTON, MA, 02421